Updates are available Correction dated 2025-01-07
Click to view Correction: https://doi.org/10.1186/s13058-024-01952-0
-
Authors
Park, Jieun
Chang, Eun Sol
Kim, Ji-Yeon
Chelakkot, Chaithanya
Sung, Minjung
Song, Ji-Young
Jung, Kyungsoo
Lee, Ji Hye
Choi, Jun Young
Kim, Na Young
Lee, Hyegyeong
Kang, Mi-Ran
Kwon, Mi Jeong
Shin, Young Kee
Park, Yeon Hee
Choi, Yoon-La
-
Funding
Funding for this research was provided by:
Ministry of Health & Welfare, South Korea (HI19C0141)
Ministry of Health & Welfare, South Korea (HI19C0141)
Ministry of Health & Welfare, South Korea (HI19C0141)
Ministry of Health & Welfare, South Korea (HI19C0141)
Ministry of Health & Welfare, South Korea (HI19C0141)
Ministry of Science and ICT, South Korea (2022R1A2C2006322)
Ministry of Science and ICT, South Korea (2022R1A2C2006322)
Ministry of Science and ICT, South Korea (2022R1A2C2006322)
Ministry of Science and ICT, South Korea (2022R1A2C2006322)
Ministry of Science and ICT, South Korea (2022R1A2C2006322)
Ministry of Science and ICT, South Korea (2022R1A2C2006322)
Samsung Medical Center (#SMO1230021)
- License Information
-
More Information
Article History
Received: 30 May 2023
Accepted: 9 January 2024
First Online: 18 January 2024
Change Date: 7 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13058-024-01952-0
Declarations
:
: The study protocol was approved by the Institutional Review Board (IRB) of the SMC (IRB No. 2019-08-119) and was conducted per the Declaration of Helsinki. Written informed consent was obtained from all the patients.
: Not applicable.
: Jieun Park and Young Kee Shin received consulting fees from ABION, Inc. Na Young Kim and Young Kee Shin currently hold stocks at ABION, Inc. Mi-Ran Kang currently holds stocks at Gencurix Inc. The other authors declare no potential conflicts of interest relevant to this study.
